Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quan Wan

Showing results (181-190 of 211) with videos related to

Pageof 22
Sort By:
Biochemical and Biophysical Research Communications|June 8, 2025
Anti-TNFR2 antibody and HMGN1 combined with TIL cell therapy inhibits colorectal cancer progression by enhancing immune responseHang Lv, Yujie Nie, Huan Gui, et al.
International Journal of Nanomedicine|April 22, 2024
Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon CancerHaohua Yuan, Huan Gui, Shuanghui Chen, et al.
Frontiers in Surgery|October 4, 2024
Clinical efficacy of unilateral laminotomy for bilateral decompression in the treatment of adjacent segment disease after lumbar fusionYun Xu, Yang Liu, Ding Ding, et al.
Frontiers in Surgery|November 13, 2024
Corrigendum: Clinical efficacy of unilateral laminotomy for bilateral decompression in the treatment of adjacent segment disease after lumbar fusionYun Xu, Yang Liu, Ding Ding, et al.
Acta Pharmacologica Sinica|January 16, 2026
Discovery of a potent and orally bioavailable type Ⅰ PRMTs inhibitor for triple-negative breast cancer treatmentShu-Yan Zhou, Qiang-Sheng Zhang, Lu Li, et al.
Journal of Hazardous Materials|April 15, 2023
Co-transport of biochar nanoparticles (BC NPs) and rare earth elements (REEs) in water-saturated porous media: New insights into REE fractionationQuan Wan, Beibei Liu, Miaoyue Zhang, et al.
Molecular Cancer Therapeutics|August 2, 2020
Targeting the Synthetic Vulnerability of <i>PTEN</i>-Deficient Glioblastoma Cells with MCL1 InhibitorsChao Chen, Sichao Zhu, Xia Zhang, et al.
Frontiers in Immunology|June 19, 2026
3M-052 combined inhibitory anti-TNFR2 synergistically suppresses colon cancer progressionQianyu Jing, Junqian Luo, Quan Wan, et al.
Iscience|August 3, 2023
Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancersDaxing Xu, Wei Qian, Zhenkun Yang, et al.
Brain Research Bulletin|January 22, 2026
Electroacupuncture alleviates inflammatory pain via the activation of GABAergic inhibitory interneurons in mouse spinal dorsal hornJiawei Zhang, Yang Bao, Mengye Zhu, et al.
Pageof 22

Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
Biochemical and Biophysical Research Communications|June 8, 2025
Anti-TNFR2 antibody and HMGN1 combined with TIL cell therapy inhibits colorectal cancer progression by enhancing immune responseHang Lv, Yujie Nie, Huan Gui, et al.
International Journal of Nanomedicine|April 22, 2024
Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon CancerHaohua Yuan, Huan Gui, Shuanghui Chen, et al.
Frontiers in Surgery|October 4, 2024
Clinical efficacy of unilateral laminotomy for bilateral decompression in the treatment of adjacent segment disease after lumbar fusionYun Xu, Yang Liu, Ding Ding, et al.
Frontiers in Surgery|November 13, 2024
Corrigendum: Clinical efficacy of unilateral laminotomy for bilateral decompression in the treatment of adjacent segment disease after lumbar fusionYun Xu, Yang Liu, Ding Ding, et al.
Acta Pharmacologica Sinica|January 16, 2026
Discovery of a potent and orally bioavailable type Ⅰ PRMTs inhibitor for triple-negative breast cancer treatmentShu-Yan Zhou, Qiang-Sheng Zhang, Lu Li, et al.
Journal of Hazardous Materials|April 15, 2023
Co-transport of biochar nanoparticles (BC NPs) and rare earth elements (REEs) in water-saturated porous media: New insights into REE fractionationQuan Wan, Beibei Liu, Miaoyue Zhang, et al.
Molecular Cancer Therapeutics|August 2, 2020
Targeting the Synthetic Vulnerability of <i>PTEN</i>-Deficient Glioblastoma Cells with MCL1 InhibitorsChao Chen, Sichao Zhu, Xia Zhang, et al.
Frontiers in Immunology|June 19, 2026
3M-052 combined inhibitory anti-TNFR2 synergistically suppresses colon cancer progressionQianyu Jing, Junqian Luo, Quan Wan, et al.
Iscience|August 3, 2023
Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancersDaxing Xu, Wei Qian, Zhenkun Yang, et al.
Brain Research Bulletin|January 22, 2026
Electroacupuncture alleviates inflammatory pain via the activation of GABAergic inhibitory interneurons in mouse spinal dorsal hornJiawei Zhang, Yang Bao, Mengye Zhu, et al.
Pageof 22